Subgroup analysis of the therapeutic effects of negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Blood Pressure and LDL-C During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Median EQ-5D-3L index values during 5 years of follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Baseline Characteristics of Included Patients. حسب Karl Ingard (22582091)

الموضوعات:

Characteristics of the included studies. حسب Si He (3236646)

الموضوعات:

Trial sequential analysis of primary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Trial sequential analysis of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Subgroup Analysis of the Occurrence of Secondary Endpoints. حسب Karl Ingard (22582091)

الموضوعات:

Pooled effect of the therapeutic effects of negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Forest plots of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. حسب Si He (3236646)

الموضوعات:

Study flow chart. حسب Karl Ingard (22582091)

الموضوعات:

Extracted data and used for analysis. حسب Si He (3236646)

الموضوعات:

Kaplan-Meier curve of the primary outcome. حسب Karl Ingard (22582091)

الموضوعات:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Excluded studies with reasons for exclusion. حسب Si He (3236646)

الموضوعات:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. حسب Karl Ingard (22582091)

الموضوعات:

Flow diagram of the studies included in the meta-analysis. حسب Si He (3236646)

الموضوعات:

Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i> حسب Ceyan Kuang (8554557)

الموضوعات:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"